Chester County News and Community Website
LANGHORNE, PA — Savara Inc. (Nasdaq: SVRA) has introduced the aPAP ClearPath Dried Blood Spot (DBS) Test in the United States, offering a groundbreaking solution for diagnosing autoimmune pulmonary alveolar proteinosis …
Savara Inc. Launches Convenient DBS Test for Diagnosing Rare Lung Disease Read More LANGHORNE, PA — Savara Inc. (Nasdaq: SVRA) announced that its management team will participate in the upcoming Leerink Global Healthcare Conference. The company will be featured in a fireside chat …
Savara Inc. to Present at Leerink Global Healthcare Conference Read More LANGHORNE, PA — Savara Inc. (Nasdaq: SVRA) has announced the grant of inducement equity awards to five new employees as part of its strategy to attract top talent to the organization. …
Savara Inc. Awards Stock Options and RSUs to New Employees Read More LANGHORNE, PA — Savara Inc. (Nasdaq: SVRA) has announced the publication of a manuscript detailing long-term outcomes for molgramostim inhalation solution in patients with autoimmune pulmonary alveolar proteinosis (aPAP). The study, …
Savara Inc. Publishes Promising Long-Term Outcomes for aPAP Treatment Read More LANGHORNE, PA — Savara Inc. (Nasdaq: SVRA) has announced its participation in two prominent healthcare investor conferences this February. Members of the company’s management team will engage in fireside chats at …
Savara Inc. to Present at Upcoming Healthcare Investor Conferences Read More LANGHORNE, PA — Savara Inc. (Nasdaq: SVRA) has announced the issuance of inducement awards to five newly hired employees as part of its ongoing efforts to attract top talent. The awards …
Savara Inc. Grants Inducement Awards to New Employees Read More LANGHORNE, PA — Savara Inc. (Nasdaq: SVRA) has initiated the rolling submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for MOLBREEVI, a potential …
Savara Begins FDA Submission for Rare Lung Disease Treatment Read More LANGHORNE, PA — Savara Inc. (Nasdaq: SVRA) has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference, where the company will present and engage in one-on-one meetings with …
Savara Inc. to Present at the 43rd Annual J.P. Morgan Healthcare Conference Read More LANGHORNE, PA — Savara Inc. (Nasdaq: SVRA) has granted equity awards to four newly hired employees, the company announced on November 20, 2024. These awards, given as part of the …
Savara Inc. Announces Stock Awards for New Employees Read More LANGHORNE, PA — Savara Inc. (Nasdaq: SVRA) has released its financial results for the third quarter ending September 30, 2024, and provided an important business update that underscores the company’s …
Savara Inc. Reports Third-Quarter Financial Results and Announces Key Regulatory Milestones Read More